Prime Medicine, Inc. (PRME) financial statements and ratios from SEC XBRL: revenue $4.63M (TTM), net margin -4342.4%, revenue growth 55.3% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $4.63M |
| Net Margin | -4342.4% |
| Revenue Growth (YoY) | 55.3% |
| EPS Growth (YoY) | -18.2% |
| FCF Growth (YoY) | 28.4% |
| Price / Book | 7.96 |
| Price / Sales | 126.79 |
| FCF Yield | -52.1% |
| Altman Z-Score | -3.47 (distress) |
| Sector P/E (Healthcare) | 21.7 |
PRME overview · PRME earnings · PRME KPIs · PRME investor relations · PRME ownership · PRME peers · PRME filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.